We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
144 hedge funds and large institutions have $283M invested in Arcturus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
181% more call options, than puts
Call options by funds: $3.53M | Put options by funds: $1.26M
0.25% less ownership
Funds ownership: 98.39% → 98.14% (-0.25%)
8% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 50
2% less funds holding
Funds holding: 147 → 144 (-3)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
37% less capital invested
Capital invested by funds: $453M → $283M (-$170M)
Holders
144
Holders Change
-3
Holders Change %
-2.04%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
46
Reduced
50
Closed
24
Calls
$3.53M
Puts
$1.26M
Net Calls
+$2.27M
Net Calls Change
+$2.31M
Top Buyers
| 1 |
Millennium Management
New York
|
+$7.33M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.18M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$4.17M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$3.36M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.44M |
Top Sellers
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$7.81M |
| 2 |
BlackRock
New York
|
-$3.64M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.97M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.57M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.55M |
